ZENTEL Albendazole 400mg Oral Suspension IP 10ml

ZENTEL Albendazole 400mg Oral Suspension IP 10ml Suspension Each 10 ml contains: Albendazole IP 400 mg in a flavoured syrup base. List of Excipients: Polysorbate 80, Glycerin, Sorbitol Solution 70%, Methylparaben, Propylparaben, Sodium carboxymethyl cellulose, Sodium saccharin, American Ice cream flavour, Cardamom flavour, Purified water, Citric Acid Monohydrate. Therapeutic Indications: ZENTEL is a benzimidazole carbamate with anthelmintic and antiprotozoal activity against intestinal and tissue parasites. Intestinal Infections And Cutaneous Larva Migrans Short duration treatment at low dose. ZENTEL is indicated in the treatment of the following clinical conditions caused by sensitive intestinal helminths/protozoa (see 5.2 Pharmacodynamic Properties): - enterobiasis (pinworm infection) - ancylostomiasis and necatoriasis (hookworm disease) - hymenolepsiasis (dwarf tapeworm infection) - taeniasis (pork/beef tapeworm infection) - strongyloidiasis (threadworm infection) - ascariasis (roundworm infection) - trichuriasis (whipworm infection) - clonorchiasis and opisthorchiasis (Opisthorchic viverrini and/or Clonorchis sinensis infections) (liver fluke infections) - cutaneous larva migrans [hookworm (animal origin) causing skin disease] - giardiasis in children (Giardia infection) DOSAGE: Only as directed by the physician. Dosages are dependent on the parasite involved, the weight of the patient, and the severity of the infection. Contraindications ZENTEL should not be administered during pregnancy, or in women thought to be pregnant. ZENTEL is contraindicated in patients with a known history of hypersensitivity to albendazole or other constituents of the dose forms. Manufacturer: GlaxoSmithKline Pharmaceuticals Limited. Made in India.